RE: Re: 10/04/2018 FINAL RESULTS5 May 2018 23:07
tozerk,
You need to read the accounts and make your own decisions. This quote is from the latest accounts:
Our Product Pipeline:
We aim to make a significant contribution in �precision� medicine and science, namely to engineer a breakthrough
into human health and well-being, through the early detection of cancer and its therapeutic intervention.
A huge market - But, the research costs, hence the need for funds as announced in the accounts. If the science proves correct then there will be a lot of value here for share holders and humanity. Unfortunately, the possibility of further dilution could cause the share price to drop until further information is released through the RNS service.
IMO, DYOR etc, do not believe what is written on bulletin boards or what motivates the poster to post.